# Immunovant, Inc.: Form SC 13D/A, filed Aug 2, 2021

- Company: [Immunovant, Inc.](/companies/imvt.md) (CIK 1764013)
- Form: SC 13D/A
- Filed: 2021-08-02
- Accepted by EDGAR: Aug 2, 2021, 08:23 ET
- Period: not reported
- Accession: 0001104659-21-098576
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1764013/000110465921098576/tm2123817d1_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1764013/000110465921098576/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1764013/000110465921098576/tm2123817d1_sc13da.htm

Filed Aug 2, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-098576. Last ingested by Listed: Nov 13, 2026, 16:26 ET. No prices; not investment advice.
